Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.
By O. Calof, Atam B. Singh, Martin L. Lee, A. Kenny, R. Urban, J. Tenover, S. Bhasin. The journals of gerontology. Series A, Biological sciences and medical sciences, 2005
696 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/66a6472f639ccd7d1a36e2151010497dc00d18ad
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- W. Hembree
- P. Cohen-Kettenis
- W. Meyer
- H. Delemarre-van de Waal
- V. Tangpricha
- N. Spack
- M. F. Holick
- L. Edwards-Leeper
Citations in the corpus
- Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. (2010, neutral): “of m al e ag in g (C on tin ue d) J Clin Endocrinol Metab, June 2010, 95(6):2560–2575 jcem.”
- Endocrine Treatment of Gender‐Dysphoric/Gender‐Incongruent Persons: An Endocrine Society* Clinical Practice Guideline (2017, neutral): “Likewise, a meta-analysis of 19 randomized trials in nontransgender males on testosterone replacement showed no increased incidence of cardiovascular events (185).”
- Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. (2018, neutral): “T administration in hypogonadal men is associated with a dose-dependent increase in hemoglobin concentrations (88); the increase in hemoglobin is greater in older men than in young hypogonadal men (89).”
- Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. (2009, background): “Likewise, a meta-analysis of 19 randomized trials examining testosterone replacement in men showed no increased incidence of cardiovascular events (113).”